Terumo Aortic announces US FDA Approval for TREO endovascular device

TREO - News Thumbnail

TREO is the only device commercially available for endovascular aneurysm repair (EVAR) with dual proximal fixation and lock stent technology offering physicians the next advancement in endovascular device solutions. It is a three-piece design featuring in situ limb adjustability and provides a wide range of aortic device configurations to specifically address the anatomy of each […]

Terumo Aortic Announces US FDA Breakthrough Device designation for Thoraflex Hybrid device

Thoraflex Hybrid - News Thumbnail

The purpose of the FDA’s Breakthrough Device Designation program is to fast-track the regulatory review process for certain medical technologies and device-led combination products that satisfy certain criteria; these include providing a more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The aim of the program is to provide patients and […]

Repair. Remodel. Results.

Discover how the TREO® Abdominal Stent-graft System supports in achieving EVAR success with sac regression.

Click to learn more

Terumo Aortic Kings Award Logo

Winner of the Kings Award for Enterprise 2024

Across every level of our business, our associates are driven by a shared purpose: to advance healthcare and enhance patients’ lives. This commitment is proudly reflected in our mission and core values.
LIVES SAVED*
5,824,352
*Based on internal shipping and sales data.

Subscribe for Email Updates